RB Capital Management LLC Raises Stake in UnitedHealth Group Incorporated (NYSE:UNH)

RB Capital Management LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,086 shares of the healthcare conglomerate’s stock after acquiring an additional 27 shares during the quarter. RB Capital Management LLC’s holdings in UnitedHealth Group were worth $2,678,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of UNH. Bray Capital Advisors grew its stake in shares of UnitedHealth Group by 0.5% in the 3rd quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock worth $4,848,000 after purchasing an additional 50 shares during the last quarter. Reston Wealth Management LLC increased its position in UnitedHealth Group by 6.0% during the third quarter. Reston Wealth Management LLC now owns 633 shares of the healthcare conglomerate’s stock worth $319,000 after buying an additional 36 shares during the last quarter. Meridian Financial Partners LLC raised its stake in shares of UnitedHealth Group by 2.1% in the 3rd quarter. Meridian Financial Partners LLC now owns 2,667 shares of the healthcare conglomerate’s stock valued at $1,418,000 after acquiring an additional 56 shares in the last quarter. Avestar Capital LLC lifted its position in UnitedHealth Group by 2.7% during the 3rd quarter. Avestar Capital LLC now owns 5,232 shares of the healthcare conglomerate’s stock worth $2,638,000 after acquiring an additional 140 shares during the last quarter. Finally, Lake Street Financial LLC increased its stake in shares of UnitedHealth Group by 3.6% in the third quarter. Lake Street Financial LLC now owns 5,144 shares of the healthcare conglomerate’s stock worth $2,624,000 after purchasing an additional 181 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have commented on UNH. Truist Financial reaffirmed a “buy” rating and issued a $600.00 price target on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Piper Sandler increased their price target on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, April 10th. Royal Bank of Canada lowered their price target on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 17th. Finally, TD Cowen decreased their price objective on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th. Four equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $570.05.

UnitedHealth Group Price Performance

Shares of UNH traded up $0.41 during mid-day trading on Wednesday, hitting $484.11. 2,623,935 shares of the company traded hands, compared to its average volume of 4,436,221. The stock has a market capitalization of $445.42 billion, a price-to-earnings ratio of 29.74, a PEG ratio of 1.42 and a beta of 0.54. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. The business has a 50-day moving average of $484.44 and a 200 day moving average of $513.42. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s revenue was up 8.6% on a year-over-year basis. During the same period last year, the company earned $6.26 EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.55%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.